Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review

Impact of nonsynonymous mutations of factor X on the functions of factor X and anticoagulant activity of edoxaban

(2015) Kengo Noguchi et al.   BLOOD COAGULATION & FIBRINOLYSIS

Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants

(2014) Adam Cuker et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

A randomized trial of the safety, pharmacokinetics and pharmacodynamics of edoxaban, an oral factor Xa inhibitor, following a switch from warfarin

(2012) Jeanne Mendell et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux

(2011) Meyer Samama et al.   THROMBOSIS AND HAEMOSTASIS

Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents

(2011) Toshio Fukuda et al.   THROMBOSIS AND HAEMOSTASIS

In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux

(2011) Meyer Michel Samama et al.   THROMBOSIS RESEARCH

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

(2010) Koichiro Ogata et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers

(2010) Jeanne Mendell et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation

(2010) Stuart Connolly et al.   THROMBOSIS AND HAEMOSTASIS

Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation

(2010) Hui-Kyung Jeon et al.   THROMBOSIS AND HAEMOSTASIS